ADD-428012

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameADD-428012
Drug Alias NameADD-428012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEpilepsyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBio-Pharm Solutions Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio-Pharm Solutions Co Ltd
Active IndicationsN/A
Inactive IndicationsEpilepsyNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A